European Medicines Agency recommends the AstraZeneca COVID-19 vaccine for use in the EU, as tensions grow over potential shortages
Published
The COVID-19 vaccine developed by Oxford University and AstraZeneca is the third vaccine to be approved in the EU. The others were developed by Moderna and Pfizer.
Full Article